日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind

将高危代谢功能障碍相关性脂肪性肝炎的诊断率提高一倍——不让任何人掉队

Abdelgadir, Elamin; Alawadi, Fatheya; Rashid, Fauzia; Bashir, Alaaeldin; Schattenberg, Jörn M

Longitudinal risk of cirrhosis by steatotic liver disease subtype among 1.5 million individuals in the US

美国150万人的脂肪肝疾病亚型与肝硬化纵向风险的关系

Sedki, Mai; Yang, Zeyuan; Singal, Ashwani K; Pessoa, Mário Guimarães; Krag, Aleksander; Schattenberg, Jörn M; Henry, Linda; Alqahtani, Saleh; Lazarus, Jeffrey V; Younossi, Zobair M; Wong, Robert J

Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis

综述文章:靶向过氧化物酶体增殖物激活受体治疗原发性胆汁性胆管炎

Schattenberg, Jörn M; Banales, Jesus M; Hirschfield, Gideon; Trivedi, Palak; Cable, Edward E; McWherter, Charles A; Billin, Andrew N; Crittenden, Daria B; Budas, Grant

Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-The-Art Review

代谢功能障碍相关脂肪肝病(MASLD)的诊疗路径:最新进展综述

van Eekhout, Kirsi M A; Broekman, Leonard D; de Jong, Vivian D; Michel, Maurice; Grobbee, Rick; Maya-Miles, Douglas; Romero-Gómez, Manuel; Muris, Jean; Mendive, Juan M; Vali, Yasaman; Franco, Oscar H; Schattenberg, Jörn M; Fournier-Poizat, Céline; Castro Cabezas, Manuel; Tushuizen, Maarten E; Holleboom, Adriaan G

Effect of Essential Phospholipids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical Trial

必需磷脂对代谢功能障碍相关脂肪肝疾病的影响:一项随机4期临床试验

Stefan, Norbert; Hartleb, Marek; Fan, Jiangao; Demir, Münevver; Schattenberg, Jörn M; Gietka, Jan; Bułdak, Łukasz; Popovic, Branko; Varona, Rafael; De Fer, Beatrice Bois

Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH)

瑞美替罗:代谢功能障碍相关性脂肪性肝炎(MASH)治疗的最新进展

Van Kleef, Laurens A; Michel, Maurice; Alkhouri, Naim; Brouwer, Willem Pieter; Schattenberg, Jörn M

Inflammatory Bowel Diseases Are Not Associated with an Increased Risk of Autoimmune Thyroiditis

炎症性肠病与自身免疫性甲状腺炎风险增加无关

Barton, Alexander; Labenz, Christian; Grabbe, Stephan; Schattenberg, Jörn M; Kaps, Leonard; Kostev, Karel

The impact of dietary interventions on liver health biomarkers in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic literature review and meta-analysis of randomized controlled trials

饮食干预对代谢功能障碍相关脂肪肝(MASLD)患者肝脏健康生物标志物的影响:一项系统性文献综述和随机对照试验的荟萃分析

Stern, Ute M; Wagenpfeil, Gudrun; Weber, Susanne N; Alqahtani, Saleh A; Michel, Maurice; Schattenberg, Jörn M

Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests

真实世界中代谢功能障碍相关性脂肪性肝炎:临床负担、疾病进展及非侵入性检测的风险分层

Sartini, Claudio; Herrera, Ronald; Mazhar, Faizan; Torres, Zuleika Aponte; Raluy, Mireia; Yates, Mark; Yousif, Alia; Younes, Ramy; Schattenberg, Jörn M

Weight Change is Associated With Metabolic Liver Health in a General Population Extending Beyond Weight Loss Targets of International Guidelines

体重变化与一般人群的代谢性肝脏健康相关,这种关联超越了国际指南规定的减重目标。

van Kleef, Laurens A; Savas, Mesut; Michel, Maurice; Caussy, Cyrielle; Pustjens, Jesse; Holleboom, Adriaan G; van Rossum, Elisabeth F C; Janssen, Harry L A; Schattenberg, Jörn M; Brouwer, Willem P